These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34331968)

  • 21. Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.
    Walker CM
    Cold Spring Harb Perspect Med; 2019 Sep; 9(9):. PubMed ID: 29844218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review.
    Lin KY; Chen GJ; Lee YL; Huang YC; Cheng A; Sun HY; Chang SY; Liu CE; Hung CC
    World J Gastroenterol; 2017 May; 23(20):3589-3606. PubMed ID: 28611512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consensus statement on the role of hepatitis A vaccination in patients with chronic liver disease.
    Cooksley WG
    J Viral Hepat; 2000 May; 7 Suppl 1():29-30. PubMed ID: 10866843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humans.
    Manangeeswaran M; Jacques J; Tami C; Konduru K; Amharref N; Perrella O; Casasnovas JM; Umetsu DT; Dekruyff RH; Freeman GJ; Perrella A; Kaplan GG
    Gastroenterology; 2012 Jun; 142(7):1516-25.e3. PubMed ID: 22430395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessing immune control of hepatitis A virus.
    Walker CM; Feng Z; Lemon SM
    Curr Opin Virol; 2015 Apr; 11():7-13. PubMed ID: 25617494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible nitric oxide synthase (iNOS) expression in liver and splenic T lymphocyte rise are associated with liver histological damage during experimental hepatitis A virus (HAV) infection in Callithrix jacchus.
    Pinto MA; Marchevsky RS; Pelajo-Machado M; Santiago MA; Pissurno JW; França MS; Baptista ML; Gouvea AS; Santana AA; Bertho AL; Schatzmayr HG; Gaspar AM; Kubelka CF
    Exp Toxicol Pathol; 2000 Mar; 52(1):3-10. PubMed ID: 10779146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.
    Kanda T; Sasaki R; Masuzaki R; Takahashi H; Mizutani T; Matsumoto N; Nirei K; Moriyama M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver-derived cytotoxic T cells in hepatitis A virus infection.
    Vallbracht A; Maier K; Stierhof YD; Wiedmann KH; Flehmig B; Fleischer B
    J Infect Dis; 1989 Aug; 160(2):209-17. PubMed ID: 2503564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection.
    Schulte I; Hitziger T; Giugliano S; Timm J; Gold H; Heinemann FM; Khudyakov Y; Strasser M; König C; Castermans E; Mok JY; van Esch WJ; Bertoletti A; Schumacher TN; Roggendorf M
    J Hepatol; 2011 Feb; 54(2):201-8. PubMed ID: 21056495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL10 is produced in hepatitis A virus-infected cells in an IRF3-dependent but IFN-independent manner.
    Sung PS; Hong SH; Lee J; Park SH; Yoon SK; Chung WJ; Shin EC
    Sci Rep; 2017 Jul; 7(1):6387. PubMed ID: 28744018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
    John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
    J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IRF3-mediated pathogenicity in a murine model of human hepatitis A.
    Sun L; Li Y; Misumi I; González-López O; Hensley L; Cullen JM; McGivern DR; Matsuda M; Suzuki R; Sen GC; Hirai-Yuki A; Whitmire JK; Lemon SM
    PLoS Pathog; 2021 Sep; 17(9):e1009960. PubMed ID: 34591933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental evidence of hepatitis A virus infection in pigs.
    Song YJ; Park WJ; Park BJ; Kwak SW; Kim YH; Lee JB; Park SY; Song CS; Lee SW; Seo KH; Kang YS; Park CK; Song JY; Choi IS
    J Med Virol; 2016 Apr; 88(4):631-8. PubMed ID: 26381440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A virological perspective on the need for vaccination.
    Locarnini S
    J Viral Hepat; 2000 May; 7 Suppl 1():5-6. PubMed ID: 10866836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparities in hepatitis A virus (HAV) vaccination coverage among adult travelers to intermediate or high-risk countries: The role of birthplace and race/ethnicity.
    Narayanan N; Elsaid MI; NeMoyer RE; Trivedi N; Zeb U; Rustgi VK
    Vaccine; 2019 Jul; 37(30):4111-4117. PubMed ID: 31196682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.
    Xiang K; Kusov Y; Ying G; Yan W; Shan Y; Jinyuan W; Na Y; Yan Z; Hongjun L; Maosheng S
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28914805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of hepatitis B virus replication mediated by hepatitis A-induced cytokine production.
    van Nunen AB; Pontesilli O; Uytdehaag F; Osterhaus AD; de Man RA
    Liver; 2001 Feb; 21(1):45-9. PubMed ID: 11169072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes.
    Feng Z; Hensley L; McKnight KL; Hu F; Madden V; Ping L; Jeong SH; Walker C; Lanford RE; Lemon SM
    Nature; 2013 Apr; 496(7445):367-71. PubMed ID: 23542590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental hepatitis A virus (HAV) infection in Callithrix jacchus: early detection of HAV antigen and viral fate.
    Pinto MA; Marchevsky RS; Baptista ML; de Lima MA; Pelajo-Machado M; Vitral CL; Kubelka CF; Pissurno JW; Franca MS; Schatzmayr HG; Gaspar AM
    Exp Toxicol Pathol; 2002 Feb; 53(6):413-20. PubMed ID: 11930901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis A viral load in relation to severity of the infection.
    Fujiwara K; Kojima H; Yasui S; Okitsu K; Yonemitsu Y; Omata M; Yokosuka O
    J Med Virol; 2011 Feb; 83(2):201-7. PubMed ID: 21181913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.